Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0750-2021

Drug recall · August 25, 2021

Tizanidine HCl Tablets recall

Why: Failed Tablet/Capsule Specification: Some tablets are shaved

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Lots / codes

Lot #: T2000471, exp date 09/2023

Quantity
37560 bottles
Company
Dr. Reddy's Laboratories, Inc., Princeton, NJ
Distribution
Nationwide within the United States
Initiated
July 19, 2021 · Voluntary: Firm initiated
Classified
August 18, 2021
Reported
August 25, 2021
Ended
December 21, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Tizanidine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.